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The aim of this study was to develop a method for simultaneous detection of antineoplastic drugs on 
gloves since, in occupational exposure, the main contamination route is through dermal contact, which 
may occur via prolonged contact with contaminated surfaces or materials. The assay was performed 
by liquid chromatography using the following conditions for the detection of 5-fluorouracil (5-FU), 
methotrexate (MTX) and paclitaxel (TAX): diode array detection and UV quantification at 195 nm for 
TAX, at 265 nm for 5-FU and at 302 nm for MTX; ODS column (250 x 4 mm, 5 µm) with a similar 
guard column; mobile phase consisted of water (pH 4)-methanol-acetonitrile (35:15:50, v/v/v) with a 
flow rate of 1 mL min-1. The method presented a linear range from 0.25 to 20 µg mL-1 with r2 higher than 
0.99. Repeatability was ≤15% and satisfactory extraction efficiency was obtained when liquid-liquid 
extraction with ethyl acetate was used for 5-FU and TAX. Satisfactory solid phase extraction was also 
achieved with C18 cartridges and elution with methanol for MTX. The diode array detector allowed drug 
quantification at a concentration ≥ 0.25 µg mL-1 in samples, although detection was possible in samples 
that presented values of around 0.1 µg mL-1. The results obtained suggest that the method developed 
can be applied for the simultaneous determination of the drugs studied and can be considered useful in 
exposure assessment for health care workers. 
Uniterms: Antineoplastic drugs/detection. Gloves/toxicologial analysis. High Performance Liquid 
Chromatography/toxicologial analysis. Occupational exposure.
O objetivo deste estudo foi desenvolver um método para a detecção simultânea de antineoplásicos em 
luvas, uma vez que, em exposições ocupacionais, a principal via de introdução é a dérmica, por meio de 
contato prolongado com superfícies e/ou materiais contaminados com tais fármacos. A tecnica de detecção 
utilizada foi a cromatografia líquida de alta eficiência, com detector de aranjo de diodos, nas seguintes 
condições: para a detecção de 5-fluorouracila (5-FU), metotrexato (MTX) e paclitaxel (TAX): detecção 
e quantificação de TAX a 195 nm, de 5-FU a 265 nm e de MTX a 302 nm; coluna ODS (250 x 4 mm, 
5 mm), com pré-coluna similar; fase móvel constituída de água (pH 4)-metanol-acetonitrila (35:15:50, 
v/v/v), na vazão de 1 mL min-1. O método apresentou uma faixa linear de 0,25-20 mg mL-1, com r2 > 0,99. 
O desvio-padrão relativo, para a avaliação da repetibilidade foi ≤ 15%; a recuperação foi satisfatória, 
empregando extração líquido-líquido, com acetato de etila, para a 5-FU e TAX e extração em fase sólida, 
com cartuchos de C18 e eluição com metanol, para MTX. O detector de arranjo de diodos permitiu a 
quantificação dos fármacos, quando presentes nas amostras em concentração ≥ 0,25 mg mL-1, embora 
a detecção foi possível nas amostras que apresentaram valores em torno de 0,1 mg mL-1. Os resultados 
obtidos sugerem que o método desenvolvido pode ser aplicado para a determinação simultânea dos 
fármacos estudados, constituindo ferramenta útil na avaliação da exposição dos trabalhadores as fármacos 
antineoplásicos.
Unitermos: Antineoplásicos/detecção. Luvas/análise toxicológica. Cromatografia líquida de alta 
eficiência/análise toxicológica.
A. M. P. P. Alcântara, R. V. Vitor, E. P. Vieira, I. Martins732
INTRODUCTION
There is a tumour risk associated to the treatment 
of patients with antineoplastic drugs. This can been con-
firmed by considering the “second tumour” risk among 
patients, which increases as a function of survival period 
and is also characterized by an increased incidence of tu-
mours among patients treated for non-neoplastic diseases, 
such as immunosuppression before organ transplantation 
(Alessio et al., 1996).
Groups exposed to antineoplastic drugs include: 
patients and family members, individuals working in 
the pharmaceutical industry, workers who prepare and 
administer the antineoplastic drugs, as well as cleaning 
personnel and researchers (Sorsa, Anderson, 1996).
Occupational exposure to these agents has been 
recognized as a potential hazard since the 1970s. Based 
on current knowledge, it is impossible to set a level of 
exposure that is considered safe. The question of whether 
exposure can be diminished by a reduction in handling is 
difficult to answer. Normally, it is reasonable to assume a 
positive correlation between use and exposure and curren-
tly, no recommended exposure limits (RELs), permissible 
exposure limits (PELs), or threshold limit values (TLVs®) 
have been established for antineoplastic drugs (Sessink et 
al., 1997; NIOSH, 2004). A balance must be found so as to 
continue the use of these beneficial drugs in patients while 
also assuring the health of personnel administering them.
Biological and environmental monitoring is essen-
tial to identify the main exposure routes and to quantify the 
potential health risks. However, risk assessment calls for 
accurate standardized sampling techniques and analytical 
methods for determining the presence of these drugs in 
different samples (Turci et al., 2003).
In most of the current chemotherapy protocols, 
antineoplastic drugs are combined, each having a diffe-
rent mechanism of action. As a consequence, healthcare 
workers may be exposed to a wide variety of these subs-
tances (Larson, Khazaeli, Dillon, 2003; Turci et al., 2003). 
Thus, it is necessary to identify certain substances that 
can be used as indicators for the presence of these drugs. 
The antineoplastic drugs of concern include cyclophos-
phamide, 5-fluorouracil and the platinum coordination 
compounds (Alessio et al., 1996). Thus, the decision on 
which agents should be evaluated for exposure should be 
based on both frequency of use and toxicity of the drugs. 
Another alternative is to develop methods able to detect 
multiple compounds simultaneously.
Research has shown that the main exposure route 
appears to be direct skin contact. Therefore, the drugs 
should be detected according to the following priorities: 
a) measurement on surfaces and materials (such as masks 
and gloves), b) measurement in biological samples and c) 
measurement in environmental samples (Alessio et al., 
1996).
Analysis of surfaces and materials is very useful 
for evaluating the presence of residual contaminants in 
workrooms as well as the effectiveness of personal pro-
tective equipment. A number of surveys have been carried 
out in oncology departments and gloves were commonly 
analyzed for antineoplastic drugs, enabling the evaluation 
of the potential dermal uptake.
Previous studies have not determined the presence of 
antineoplastic drugs in cotton gloves worn under the latex 
gloves or on the inside of gloves as liners (Sessink et al., 
1992; Minoia et al., 1998). Also, no statistically significant 
differences have been observed in the levels of these drugs 
in biological safety hood surfaces, gloves or infusion bags 
(Martins, Apostoli, Della Rosa, 2008).
High performance liquid chromatography with 
ultra-violet detection (HPLC-UV) is the most used me-
thod reported in the current literature for the detection of 
antineoplastic agents. This technique appears to be the 
most feasible for attaining maximal sensitivity (a lower 
limit of detection) when used for the detection of multiple 
antineoplastics in both air and surface samples (Turci et 
al., 2002; Larson, Khazaeli, Dillon, 2003).
Since workers are exposed to a wide variety of anti-
neoplastic drugs, it is necessary to develop methods able 
to detect various agents. Currently, acceptable analytical 
methods do exist for the detection of several antineoplas-
tic drugs, but usually are only available for an individual 
agent or for small groups of chemically similar agents. 
The aim of this study was to develop a HPLC me-
thod able to detect the presence of antineoplastic drugs 
on gloves in a single analysis. The drugs evaluated were 
methotrexate (MTX), 5-fluorouracil (5-FU) and paclita-
xel (TAX). The objective was to obtain an accurate and 
sensitive liquid chromatographic method for the detection 
and quantification of these substances, which differ both 
chemically and structurally (Figure 1 and Table I), for the 
evaluation of general occupational exposure. 
Methotrexate (MTX) is an antimetabolite used in 
the treatment of certain neoplastic diseases, several forms 
of psoriasis, and adult rheumatoid arthritis. The degree 
and severity of the side effects depend on the regimen of 
administration of this drug. According to the International 
Agency for Research on Cancer (IARC), MTX is classified 
as Group 3; it is not classified as to its carcinogenicity to 
humans, but it is a known mutagen and human teratogen. 
5-fluorouracil (5-FU) is an antimetabolite frequently used 
in the treatment of cancers of the gastrointestinal tract, 
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TABLE I - Molar mass, pKa and solubility of three antineoplastic drugs frequently used in clinical practice (Reynolds, 1996; O’Neil, 
2006; Scifinder, 2006)
Drug Molar mass pKa Solubility in
5-Fluorouracil 130 7.68 water and alcohols 
Methotrexate 454 3.54/5.09 acidic and basic diluted solutions 
Paclitaxel 854 Not available organic solvents
FIGURE 1 - Chemical structure of three antineoplastic drugs, frequently used in clinical practice.
lung and breast. This drug is also classified as Group 3. 
Paclitaxel (TAX) is a diterpene alkaloid isolated from the 
bark of the Pacific yew tree. It is an anti-microtubule agent 
and is the active component in Taxol, a clinically effective 
chemotherapeutic agent approved for the treatment of 
various cancers. Due to its use being very recent, it has 
so far not been possible to classify taxol according to its 
carcinogenicity, mutagenicity or teratogenicity. However, 
is should be considered similar to other potentially toxic 
compounds and caution must be exercised in handling 
TAX (Turci et al., 2003). Table I lists several observed 
characteristics of these compounds.
MATERIAL AND METHODS
Chemicals
Methotrexate, 5-fluorouracil and paclitaxel were 
purchased from the Sigma-Aldrich® chemical company 
(St Louis, USA) and were > 99% pure. HPLC-grade me-
thanol, ethyl acetate and sodium acetate were purchased 
from Vetec® (Duque de Caxias, Brazil). HPLC-grade 
acetonitrile was purchased from Mallinckrodt Baker Inc. 
(Paris, France). All other chemicals were of analytical-
grade and of the highest purity available. Water was dis-
tilled and purified using a Millipore® Milli-Q Plus system 
(Bedford, USA).
Standard and stock solutions
Stock standard solutions were prepared by dissolu-
tion of each drug in methanol to obtain a concentration of 
1 mg mL-1. These solutions were stored at -20 ºC between 
experiments. The working solutions were freshly prepared 
each day by making a 10-fold dilution of the stock solution 
in methanol.
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Chromatographic conditions
The HPLC system consisted of a Shimadzu LC-
10ATvp (Kyoto, Japan) gradient system equipped with 
a Shimadzu SIL-10AF (Kyoto, Japan) auto-injector with 
a 50 µL loop. The column oven used was a Shimadzu 
CTO-10ASvp (Kyoto, Japan) operated at a temperature 
of 35 ºC. Detection was performed with a Shimadzu SPD-
M10Avp (Kyoto, Japan) diode array detector (DAD). Data 
acquisition and treatment was performed by Class-VP 
software (Shimadzu). The assay was performed by liquid 
chromatography under the following conditions for the 
detection of 5-fluorouracil (5-FU), methotrexate (MTX) 
and paclitaxel (TAX): diode array detection and UV quan-
tification at 195 nm for TAX, at 265 nm for 5-FU and at 
302 nm for MTX; ODS column (250 x 4 mm, 5 µm) with 
a similar guard column; mobile phase consisted of water 
(pH 4)-methanol-acetonitrile (35:15:50, v/v/v) with a flow 
rate of 1 mL min-1.
Sampling
In order to apply the method, six pairs of Descar-
pack® latex surgical gloves, used during the work shift, 
were collected at a research laboratory in Alfenas, Minas 
Gerais, Brazil. In this laboratory, the pharmacists test the 
antineoplastic drugs on animals and carry out analytical 
determinations. In order to verify the handling of the drug, 
the workers answered a questionnaire. The gloves were 
only worn during the handling of the drugs. Four pairs of 
gloves were utilized during the antineoplastic manipula-
tion and collected before the decontamination procedures 
while two pairs were collected after the decontamination 
that consisted of washing with ethanol and sodium hypo-
chlorite. Samples were stored in a glass jar and transported 
to the laboratory in an ice cooler frozen at -20 °C until 
analysis. For method control three pairs of gloves used 
by pharmacists that do not handle the drugs studied, were 
also collected in this laboratory.
Sample preparation
After sampling, the gloves were placed in a glass jar 
to which 20 mL of sodium hydroxide solution (0.03 mol 
L-1) was added. After sonication (30 minutes) and shaking 
(30 minutes), the extract was centrifuged (10 minutes at 
580 g) and the supernatant was extracted according to the 
procedures below by liquid-liquid extraction (LLE) and 
solid phase extraction (SPE).
Subsequently, 1 mL of the supernatant was placed in 
a tube and extracted twice with 5 mL of ethyl acetate. The 
organic layers were combined and dried under nitrogen. 
Finally, the dried residue was dissolved by the eluate of 
SPE.
The SPE study was performed on a Vac-Elut vacuum 
manifold column processor obtained from Supelco® (Bel-
lefonte, USA). C-18 cartridges 500 mg/3 mL were sup-
plied by Supelco® (Bellefonte, USA). A C18 cartridge was 
activated with 10 mL of methanol and 10 mL of sodium 
acetate buffer (0.05 moL L-1; pH 4). A 1 mL volume of su-
pernatant sample was then added, and the sorbent washed 
with 10 mL of ethyl acetate. The cartridge was dried for 
1 min. The elution was performed with 3 mL of methanol 
(in 3 aliquots), at a constant flow rate of 1 mL min-1. The 
eluate was collected in the tube containing the dried resi-
due of the liquid-liquid extraction and evaporated under 
a flow of nitrogen. The residue was dissolved in 1 mL of 
the mobile phase, and 50 µL of this was chromatographed.
Validation
Validation of this study was done in compliance 
with IUPAC guidelines (IUPAC, 2002). The following 
parameters were assayed: robustness, linearity, lower limit 
of detection (LOD) and quantification (LOQ), precision 
and recovery. All parameters were obtained by applying 
several drops of a solution of known concentration to a 
matrix (clean gloves). 
Robustness was performed at the middle level 
(5 mg mL-1) and was explored using mobile phase flow rate 
and column temperature. Linearity was tested by examina-
tion of a plot of residuals produced by linear regression of 
the responses on the amounts of the analytes in a calibration 
set, between 0.25 and 20 mg mL-1, in 6 replicates for each 
level. A calibration curve was generated for each analytical 
run, in duplicate, and consisted of a blank and six non-zero 
samples covering the expected range, including LOQ. 
The LOD was obtained by successive dilutions to 
determine the lowest concentration with a signal-to-noise 
ratio of 3:1 and was also calculated as 3 SD (standard 
deviation) of 6 independent complete determinations 
of analyte concentration in a typical matrix blank, with 
no censoring of zero or negative results. The LOQ was 
obtained by successive dilutions to determine the lowest 
concentration with a signal-to-noise ratio of 10:1 and with 
a 10% RSD (relative standard deviation) in ten replicates.
Precision was determined through five replicate 
analyses of samples containing known amounts of the 
analytes, using the LOQ, middle and high levels, during a 
single analytical run (repeatability), and was assessed by 
relative standard deviation (RSD%), which was calculated 
as 100 x SD/mean measured concentration. Recovery was 
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FIGURE 2 - Spectra from a Shimadzu SPD-M10Avp (Kyoto, 
Japan) diode array detector, for standard solutions of 
methotrexate, 5-fluorouracil and paclitaxel (5 µg mL-1); mobile 
phase: water (pH 4)-methanol-acetonitrile (35:15:50, v/v/v); 
column: SupelcosilTM LC-18 (250 x 4.6 mm, 5 mm) protected 
by a C18 guard-column (4 x 4.6 mm, 5 mm).
determined by five replicate analyses of samples after the 
additional spiking of a known mass of the analyte in the 
non-contaminated samples. The results were compared 
with those obtained when the analyte was spiked after the 
clean-up procedure of the sample.
RESULTS AND DISCUSSION
Since workers are exposed to a wide variety of 
antineoplastic drugs, it is necessary to identify certain 
substances that can be used as indicators or to develop 
methods able to detect multiple agents. The aim of this 
study was to develop an HPLC method able to detect and 
quantify three structurally/chemically different drugs used 
in clinical practice, on gloves in a single analysis. The 
drugs evaluated were methotrexate (MTX), 5-fluorouracil 
(5-FU) and paclitaxel (TAX). These agents were included 
in this study based on their frequency of use in cancer 
hospitals and their potential human health hazard. 
HPLC conditions and sample preparation
Figure 2 shows the UV spectra of the drugs in a DA 
detector. A wavelength of 195-210 nm indicated strong 
absorption for all three agents of interest while other wa-
velengths, with lower absorptions but greater specificity, 
detected the drugs. In the literature, 260 to 266 nm light 
has been used for 5-FU (Stiles, Allen Jr., Prince, 1996), 
303 nm to 313 nm for MTX (Rubino, 2001) and 195 nm to 
detect 5-FU and TAX simultaneously (Larson, Khazaeli, 
Dillon, 2003).
Chromatographic conditions were chosen according 
to results obtained from the optimization method and pre-
vious study (Alcântara et al., 2009) to obtain satisfactory 
chromatographic separations for all compounds, in addi-
tion to a satisfactory total time for the analysis. Methanol 
has a UV cut off at 205 nm, and this was a factor limi-
ting the solvent level in the mobile phase to 15% so that 
sensitivity of the detector would not be affected. Analysis 
of the mobile phase, analyte-free, did not show any inter-
ference in the retention time of the compounds studied.
In general, the best system suitability, as demonstrated 
in Table II, was obtained with a C18 reverse phase column 
(250 x 4.6 mm, 5 µM) and a mobile phase consisting of wa-
ter (pH 4)-methanol-acetonitrile (35:15:50, v/v/v) at a flow 
rate of 1.0 mL min-1. Plates (N) were calculated to evaluate 
the efficiency of the chromatographic column, tailing factor 
(T) was a measure of peak tailing, resolution (Rs) described 
how well species have been separated and retention factor 
(k) was used to describe the migration rate of analytes on 
the column. The system was suitable since the results of 
the tests were considered satisfactory, according to criteria 
by Shabir, who reported the following acceptable ranges: 
N > 2000, T ≤ 2.0, Rs > 2 and k > 2 (Shabir, 2003). It is 
evident that MTX and 5-FU co-eluted, although this was not 
considered a problem since the detector is able to analyse the 
TABLE I I  -  System suitability parametersa calculated 
for antineoplastic drug determination with C18 column 
(250 x 4.6 mm, 5 µM) and a mobile phase consisting of water 
(pH4): methanol:acetonitrile (35:15:50, v/v/v) at a flow rate of 
1.0 mL min-1, with diode array detector
N Rsb T k
Methotrexate 2323 1.3 1
5-Fluorouracil 5987 1.4 2
Paclitaxel 16052 12.6 1.2 7
aN= plate number; Rs= resolution; T= tailing factor; k= retention 
factor for the first analyte eluted. bResolution was calculated 
between: paclitaxel and 5-fluorouracil
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sample at various wavelengths simultaneously. In fact, this 
property increased the selectivity of the method. Thus, for 
quantification, 195 nm was selected for TAX, 265 nm was 
selected for 5-FU and 302 nm was selected for MTX, in all 
analyses. The typical peak separation and response using 
this analytical method is shown in Figure 3. The retention 
times obtained were: 2.7 minutes for methotrexate, 2.9 
minutes for 5-fluorouracil and 8.9 minutes for paclitaxel, 
with a total time for the chromatographic determination of 
10 min. Real samples that presented peaks with retention 
time of 2.6 to 3.0 minutes are compared against the second 
derivative spectrum, in a library developed with standard 
solutions of the three analytes.
Validation
Table III provides information on the linearity of 
the assayed method. Linearity was evaluated by a plot of 
peak area of analyte versus theoretical concentration for 
the range 0.25 to 20 mg mL-1. The assay showed linearity, 
and regression equations revealed good correlation coef-
ficients for all analytes.
Robustness was demonstrated using a ten percent 
deviation in flow rate of the mobile phase and column 
temperature: these variations did not influence the re-
sults. These were compared with the results obtained by 
the proposed method, and the relative standard deviation 
was ≤ 5.0%. 
The lower limits of detection were 0.1 µg mL-1 for 
MTX and 0.2 µg mL-1 for both 5-FU and TAX. Two criteria 
were used for LOQ, accuracy/ precision and signal-to-noi-
se ratio, and the results were similar. The LOQ was found 
to be 0.25 µg mL-1 for all analytes (50 µL was injected into 
the column) and this value was considered satisfactory. 
Roberts et al. (2006) investigated the removal and 
deactivation of antineoplastic contamination from surfaces 
of a pharmaceutical isolator workstation. Three markers 
were used: 5-fluorouracil, cyclophosphamide and doxor-
rubicin. Detection and quantification limits for 5-FU were 
0.2 µg mL-1 and 0.5 µg mL-1, respectively. 
 The limits of detection for 5-FU and MTX were 
0.3 and 3 µg mL-1, respectively, for boxes and drug vials/
ampoules, as obtained by Sessink et al., 1992 using HPLC 
methods. The difference between the analyses was the 
mobile phase. This consisted of a sodium acetate buffer 
for 5-FU but, for elution of MTX, it was necessary to use 
a blend of sodium acetate buffer and methanol. 
The lower concentration of the range evaluated 
by Larson et al. (2003) for 5-FU was 0.5 µg mL-1 and 
for TAX was 2.0 µg mL-1. These researchers developed 
an HPLC method for the simultaneous determination of 
five antineoplastics, in a single analysis. 5-FU appeared 
at 3.45 min and paclitaxel at 38.6 min. An isocratic flow 
was used for 20 minutes, using potassium phosphate buffer 
(10 mmol L-1)-acetonitrile (77.25:22.75, v/v). During the 
gradient phase for TAX elution, the acetonitrile amount 
was increased to 70%. The total run time was 60 minutes.
Repeatability and inter-assay tests were performed 
to verify the precision of the proposed method, and these 
FIGURE 3  -  Typical chromatogram for methotrexate, 
5-fluorouracil and paclitaxel (5 µg mL-1), in a single run, 
detected at three wavelengths on a Shimadzu SPD-M10Avp 
(Kyoto, Japan) diode array detector (DAD); mobile phase: 
water (pH 4)-methanol-acetonitrile (35:15:50, v/v/v); column: 
SupelcosilTM LC-18 (250 x 4.6 mm, 5 mm) protected by a C18 
guard-column (4 x 4.6 mm, 5 mm).
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TABLE III - Slope (mAU/mg mL-1) and intercept (mAU), with standard deviation (SD) and correlation coefficient in the range 0.25 
to 20 mg mL-1, and limits of detection and quantification for the proposed method
Drug Slope (±SD) Intercept (±SD) Correlation 
coefficient (r)





methotrexate 166616 (±1626) 97891 (±8297) 0.99 0.1 0.25
5-fluorouracil 277035 (±6745) 22936 (±3443) 0.99 0.2 0.25
paclitaxel 349322 (±4863) 20519 (±2482) 0.99 0.2 0.25
were evaluated by the relative standard deviation (%). 
These values are shown in Table IV. The results obtained 
can be considered satisfactory from the 3 levels evaluated, 
since all values were below 15% thus meeting the criteria 
adopted for acceptability.
SPE procedures were described for determination 
of MTX (Turci, Micoli, Minoia, 2000), 5-FU (Micoli et 
al., 2001; Castiglia et al., 2008) and TAX (Willey et al., 
1993; Sottani et al., 1998) in environmental and biological 
samples. However, in this study, LLE was evaluated first 
for the three analytes. After several tests, the results de-
monstrated that a single technique was not able to clean up 
the samples or satisfactorily extract all compounds studied. 
A simple and fast LLE double extraction with ethyl acetate 
demonstrated satisfactory extraction efficiency (Table IV), 
for 5-FU and TAX, which are analytes (mainly TAX) with 
lipid solubility, according to Table I. This solvent was 
previously utilised by Coe et al. (1996) for the detection 
of 5-FU in plasma samples and by Satanic et al. (2000) for 
the detection of TAX in environmental samples. Although 
the recovery for TAX at level 2 of µg mL-1 was 71.3%, the 
analyses were precise, and at the high and low levels, the 
extraction efficiency was > 89.0%.
Since MTX is a more polar compound, SPE was 
evaluated. Octadecyl-bonded silica was activated with a 
methanol and sodium acetate buffer (0.05 moL L-1; pH 4) 
and, after the application of the sample, was washed with 
ethyl acetate and eluted with methanol. These were the best 
conditions obtained in the present study, as shown in Table 
IV. This procedure was based on a study for the detection of 
MTX in wipe samples (Turci, Micoli, Minoia, 2000) with 
some modifications. Thus, by adding the SPE eluate to the 
LLE residue, it was possible to detect and quantify the three 
compounds in a single chromatographic run. 
Application of the method
For application of the proposed method, six pairs 
of gloves were collected in a research laboratory. The 
results, shown in Table V indicated that MTX and TAX 
were detected and quantified in three samples. On the 
other hand, 5-FU was detected in all samples, but the 
drug was quantified in only three samples by this method. 
The results suggest that the standardized operational 
procedures in this laboratory need revision, since conta-
mination was observed in samples 5 and 6, even though 
the researchers believed they had decontaminated these 
samples with ethanol and sodium hypochlorite before 
collection. In the gloves analyzed for method control, 
the results for all samples were below the detection limit, 
and consequently were not detected or quantified by the 
proposed method.
Sessink et al. (1992) analyzed latex gloves used du-
ring the preparation of cyclophosphamide, 5-fluorouracil 
and methotrexate as well as those used during cleaning of 
hoods. The permeation of these gloves was determined 
TABLE IV  - Intra-assay (repeatability) and inter-assay 
(intermediate precision) tests, evaluated by the relative standard 
deviation (RSD%) and recovery of the liquid-liquid extraction 
for 5-fluorouracil (5-FU) and paclitaxel (TAX) and the solid 
phase extraction for methotrexate (MTX), in gloves analysed 




intra-assay (RSD%) 8.2 13.2 14.0
inter-assay (RSD%) 9.5 2.5 14.3
recovery (%) 105.1 105.7 86.3
5-FU
intra-assay (RSD%) 8.1 13.1 13.0
inter-assay (RSD%) 12.2 7.1 11.7
recovery (%) 90.7 103.3 94.3
TAX
intra-assay (RSD%) 9.6 14.8 9.8
inter-assay (RSD%) 14.1 2.6 8.8
recovery (%) 89.9 71.3 96.5
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by wearing cotton gloves under the latex gloves. The two 
types of gloves were collected separately and the analysis 
of the cotton gloves was performed in the same manner 
as for the latex gloves. In 1997, another investigation was 
carried out to re-evaluate following additional protective 
measures (Sessink et al., 1997). 
In a study conducted by Connor (1999), the perme-
ability of four glove materials to various antineoplastic 
drugs was studied. One latex glove sample was permea-
ted by carmustine, and paclitaxel permeated one sample 
each of the polyurethane and neoprene materials. Nitrile 
rubber, latex, polyurethane, and neoprene gloves were 
impermeable to 18 antineoplastic drugs in most, but not 
all, cases.
Neoprene, natural rubber latex, and nitrile gloves 
displayed the highest resistance to permeation of the 13 
cytotoxic agents studied by Wallemacq et al. (2006). The 
authors discussed that additional factors, such as duration 
of exposure, glove thickness, and drug liposolubility and 
molar mass, also affected permeability. 
Minoia et al. (1998) analyzed the inside lining of 
the gloves for contamination by cyclophosphamide and 
ifosfamide. After use, the left and the right gloves were 
collected together. In order to test the permeability of the 
gloves, one subject wore a double pair of vinyl gloves. 
In a previous study, drug contamination was shown 
on several surfaces of infusion bags, which may have been 
contaminated by gloves used by health care workers, in the 
chemotherapy handling sites. This can increase the risk of 
exposure in other areas of a hospital (Martins, Apostoli, 
Della Rosa, 2008). 
The results of the present study support the initial 
objective of establishing an HPLC method capable of si-
multaneously detecting three frequently used drugs, which 
can be considered indicators of exposure. This method 
allows evaluation of occupational exposure. Some of the 
measures recommended to control occupational exposure 
and protect the health of staff who are in routine contact 
with antineoplastic drugs in the workplace include: envi-
ronmental and biological monitoring, health monitoring, 
the adoption of information programs, training of staff 
and the use of environmental and personal protective 
equipments.
CONCLUSIONS
A suitable high-performance liquid chromatography 
method was developed and validated, using LLE and 
SPE as the extraction procedures, for the simultaneous 
detection of methotrexate, 5-fluorouracil and paclitaxel 
in gloves. This can provide information on occupational 
exposure of personnel to these drugs. The major advantage 
of this method over similar methods is that it is performed 
in isocratic mode and the chromatographic run is very fast. 
In addition, the method should use relatively inexpensive 
equipment and sample preparation techniques which are 
commonly employed in routine analyses of drugs. The 
development of appropriate procedures for sample pre-
paration and concentration might extend the applicability 
of this method to other matrices. 
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